Literature DB >> 15711816

[Long-term course of necrobiotic xanthogranuloma with ocular involvement].

S Meyer1, M Landthaler, S Hohenleutner.   

Abstract

The clinical features of necrobiotic xanthogranuloma (NX) have been presented in a series of case reports, but there are hardly any reports on the clinical long-term course of this rare and usually chronic entity. Therapeutic recommendations are mostly based on individual observations, lacking general therapeutic guidelines. To illustrate a typical chronic and progressive course of NX, we report the case of a 64-year-old woman with periorbital NX, ocular involvement and IgG paraproteinemia. Diagnosed with NX for the first time in 1993, the patient was already presented in this journal in 1995. Since then a series of therapeutic options including medication with dapsone, chlorambucil, interferon-alpha, clofazimine, melphalan, fumaric acid esters, surgical treatment and other physical therapies such as radiation, plasmapheresis, and photodynamic therapy have been applied. None of these therapeutic approaches, however, showed a satisfying long-term effect. At present the patient is undergoing cyclophosphamide-dexamethasone pulse therapy.

Entities:  

Mesh:

Year:  2006        PMID: 15711816     DOI: 10.1007/s00105-005-0903-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  23 in total

Review 1.  Necrobiotic xanthogranuloma with IgA multiple myeloma: a case report and literature review.

Authors:  E A Valentine; H D Friedman; K W Zamkoff; B W Streeten
Journal:  Am J Hematol       Date:  1990-12       Impact factor: 10.047

2.  [Necrobiotic xanthogranuloma in paraproteinemia].

Authors:  K Rappersberger; F Wrba; R Heinz; E Zonzits; H Hönigsmann
Journal:  Hautarzt       Date:  1989-06       Impact factor: 0.751

3.  Necrobiotic xanthogranuloma with orbital involvement.

Authors:  J Luck; A Layton; B A Noble
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

4.  Necrobiotic xanthogranuloma with IgA paraproteinemia and extracutaneous involvement.

Authors:  J S Fortson; A L Schroeter
Journal:  Am J Dermatopathol       Date:  1990-12       Impact factor: 1.533

5.  [Necrobiotic xanthogranuloma with paraproteinemia].

Authors:  P Y Venencie; S Doukan; A Vieillefond; C Boyer-Neumann; N D Toan; J L Beaumont; G Tchernia; J F Delfraissy
Journal:  Ann Dermatol Venereol       Date:  1992       Impact factor: 0.777

6.  Radiation therapy for ocular necrobiotic xanthogranuloma.

Authors:  D H Char; P E LeBoit; B M Ljung; W Wara
Journal:  Arch Ophthalmol       Date:  1987-02

Review 7.  Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil.

Authors:  S Machado; R Alves; M Lima; I Leal; A Massa
Journal:  Eur J Dermatol       Date:  2001 Sep-Oct       Impact factor: 3.328

8.  Necrobiotic xanthogranuloma with paraproteinaemia.

Authors:  A W Macfarlane; J L Verbov
Journal:  Br J Dermatol       Date:  1985-09       Impact factor: 9.302

9.  Histopathology of necrobiotic xanthogranuloma with paraproteinemia.

Authors:  M C Finan; R K Winkelmann
Journal:  J Cutan Pathol       Date:  1987-04       Impact factor: 1.587

10.  Ophthalmic features of necrobiotic xanthogranuloma with paraproteinemia.

Authors:  D M Robertson; R K Winkelmann
Journal:  Am J Ophthalmol       Date:  1984-02       Impact factor: 5.258

View more
  1 in total

1.  [Disseminated necrobiotic xanthogranuloma].

Authors:  M Klingner; G Hansel; J Schönlebe; U Wollina
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.